Third Rock Ventures — 2022 Investments

1 investments dated 2022 · listed companies and verified rows first · show all

MOMA Therapeuticsmomatx.com in 𝕏May 2022 · $150M

A drug discovery company staffed by scientists and industry specialists focused on developing pharmaceutical candidates.

Biotech

Timur Yusufzai(Founder)inAsit Parikh(Chief Executive Officer)in

Co-investorsNextech Invest Alexandria Casdin Capital Creacion Ventures Goldman Sachs Invus +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.